Jamison, PA, United States of America

Zilun Hu

USPTO Granted Patents = 26 

 

 

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 148(Granted Patents)


Location History:

  • Thornton, PA (US) (2006 - 2009)
  • Jamison, PA (US) (2007 - 2021)

Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Zilun Hu in Pharmaceuticals

Introduction

Zilun Hu is an accomplished inventor based in Jamison, Pennsylvania, with an impressive portfolio of 25 patents. His work primarily focuses on developing innovative pharmaceutical compounds that target crucial biochemical processes. He is currently affiliated with Bristol Myers Squibb Company, a leader in biopharmaceutical innovation.

Latest Patents

Among Zilun Hu's latest inventions are two notable patents with significant therapeutic implications:

1. **Macrocycles as Factor XIa Inhibitors**

This invention provides compounds of Formula (I) or its stereoisomers, tautomers, or pharmaceutically acceptable salts. These compounds serve as selective Factor XIa inhibitors or as dual inhibitors of Factor XIa and plasma kallikrein. The invention also includes pharmaceutical compositions that leverage these compounds, aiming to treat thromboembolic and inflammatory disorders effectively.

2. **Lactam, Cyclic Urea and Carbamate, and Triazolone Derivatives as Potent and Selective ROCK Inhibitors**

This patent presents compounds of Formula (I) or their stereoisomers, tautomers, or pharmaceutically acceptable salts. The focus is on these compounds as selective ROCK inhibitors. This innovation also encompasses pharmaceutical compositions intended to treat a range of conditions, including cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and inflammatory disorders.

Career Highlights

Throughout his career at Bristol Myers Squibb Company, Zilun Hu has demonstrated exceptional skill in translating scientific research into practical applications that address significant medical needs. His inventive work has been fundamental in advancing the company’s mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.

Collaborations

Zilun collaborates closely with esteemed colleagues such as Mimi Lifen Quan and Joanne M Smallheer. These collaborations have undoubtedly contributed to the innovative success of his research endeavors, facilitating the development of breakthrough therapeutic solutions.

Conclusion

Zilun Hu stands out as a remarkable inventor whose work continues to shape the landscape of pharmaceutical innovation. With a dedication to advancing medical sciences through his patents, he exemplifies the spirit of ingenuity and collaboration in addressing critical health challenges. His contributions are sure to leave a lasting impact on the field and enhance patient outcomes in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…